Zealand Pharma ZLDPF Stock
Zealand Pharma Price Chart
Zealand Pharma ZLDPF Financial and Trading Overview
| Zealand Pharma stock price | 40 USD |
| Previous Close | 43 USD |
| Open | 40 USD |
| Bid | 37.57 USD x 10000 |
| Ask | 41.95 USD x 20000 |
| Day's Range | 40 - 40 USD |
| 52 Week Range | 35.93 - 83.12 USD |
| Volume | 1.5K USD |
| Avg. Volume | 482 USD |
| Market Cap | 2.67B USD |
| Beta (5Y Monthly) | 0.593 |
| PE Ratio (TTM) | 6.734007 |
| EPS (TTM) | 6.03 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ZLDPF Valuation Measures
| Enterprise Value | -11270259712 USD |
| Trailing P/E | 6.734007 |
| Forward P/E | -34.48276 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.5753762 |
| Price/Book (mrq) | 0.99920267 |
| Enterprise Value/Revenue | -2.427 |
| Enterprise Value/EBITDA | -4.849 |
Trading Information
Zealand Pharma Stock Price History
| Beta (5Y Monthly) | 0.593 |
| 52-Week Change | -51.68% |
| S&P500 52-Week Change | 14.15% |
| 52 Week High | 83.12 USD |
| 52 Week Low | 35.93 USD |
| 50-Day Moving Average | 46.77 USD |
| 200-Day Moving Average | 50.81 USD |
ZLDPF Share Statistics
| Avg. Volume (3 month) | 482 USD |
| Avg. Daily Volume (10-Days) | 150 USD |
| Shares Outstanding | 66.8M |
| Float | 55.21M |
| Short Ratio | N/A |
| % Held by Insiders | 0.53% |
| % Held by Institutions | 40.87% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 59.02% |
| Operating Margin (ttm) | 85.92% |
| Gross Margin | 100.00% |
| EBITDA Margin | 50.04% |
Management Effectiveness
| Return on Assets (ttm) | 7.80% |
| Return on Equity (ttm) | 16.31% |
Income Statement
| Revenue (ttm) | 4.64B USD |
| Revenue Per Share (ttm) | 65.97 USD |
| Quarterly Revenue Growth (yoy) | -50.60% |
| Gross Profit (ttm) | 4.64B USD |
| EBITDA | 2.32B USD |
| Net Income Avi to Common (ttm) | 2.74B USD |
| Diluted EPS (ttm) | 5.94 |
| Quarterly Earnings Growth (yoy) | -48.29% |
Balance Sheet
| Total Cash (mrq) | 14.46B USD |
| Total Cash Per Share (mrq) | 208.33 USD |
| Total Debt (mrq) | 411M USD |
| Total Debt/Equity (mrq) | 2.28 USD |
| Current Ratio (mrq) | 13.979 |
| Book Value Per Share (mrq) | 40.031918 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1753067008 USD |
| Levered Free Cash Flow (ttm) | -2063679360 USD |
Profile of Zealand Pharma
| Country | United States |
| State | N/A |
| City | Søborg |
| Address | Sydmarken 11 |
| ZIP | 2860 |
| Phone | 45 88 77 36 00 |
| Website | https://www.zealandpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 578 |
Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States. The company has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. It also provides Zegalogue, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon for treating congenital hyperinsulinism. In addition, the company developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. The company was incorporated in 1997 and is based in Søborg, Denmark.
Q&A For Zealand Pharma Stock
What is a current ZLDPF stock price?
Zealand Pharma ZLDPF stock price today per share is 40 USD.
How to purchase Zealand Pharma stock?
You can buy ZLDPF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Zealand Pharma?
The stock symbol or ticker of Zealand Pharma is ZLDPF.
Which industry does the Zealand Pharma company belong to?
The Zealand Pharma industry is Biotechnology.
How many shares does Zealand Pharma have in circulation?
The max supply of Zealand Pharma shares is 66.8M.
What is Zealand Pharma Price to Earnings Ratio (PE Ratio)?
Zealand Pharma PE Ratio is 6.63349900 now.
What was Zealand Pharma earnings per share over the trailing 12 months (TTM)?
Zealand Pharma EPS is 6.03 USD over the trailing 12 months.
Which sector does the Zealand Pharma company belong to?
The Zealand Pharma sector is Healthcare.
